Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNausea is the side effect people on Mounjaro talk about most. It tends to arrive in the first week or two, ease off between doses, then flicker back whenever the dose steps up. For most people it stays mild and short-lived, but knowing why it happens and which practical steps genuinely help makes it far easier to ride out. Mounjaro (tirzepatide) is a prescription-only medicine, so any changes to how or when you take it should be discussed with your prescriber rather than decided alone — but the information below will help you have that conversation with confidence. The tirzepatide overview on our site covers the broader picture if you want it.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro activates two gut-hormone receptors, GIP and GLP-1, which together signal the brain to reduce appetite and slow the rate at which the stomach empties. That slowing effect is part of why the medicine works so well for weight loss, food stays in the stomach longer, so you feel full sooner and for longer. The downside is that the brain can misread a stomach that empties slowly as one that is struggling, and the result is nausea.
The NHS medicine page for tirzepatide lists nausea, vomiting, diarrhoea, constipation and indigestion as the most commonly reported side effects, and they share the same root cause: the digestive system adjusting to a new pace. This is also why nausea tends to return briefly each time the dose increases, the stomach needs to recalibrate again.
One thing that surprises people is how variable it is. Someone on the same dose as you might feel nothing; you might feel queasy by mid-morning. Factors like body weight, how quickly you eat, whether the meal was fatty or large, and even stress levels all play a role. That variability can feel unfair, but it does mean there are real levers you can pull. You can find more on how related symptoms fit together on our general guide to feeling unwell on Mounjaro.
This is the real question most people face around week two or three: is this nausea something I manage with small changes, or is it bad enough that I need clinical input? The answer usually sits in one of three places.
If nausea is mild and comes in waves, especially on the day of your injection or the morning after, adjusting how and what you eat is usually enough. Smaller meals spaced more evenly through the day, chewing slowly, avoiding very greasy or spiced foods, and keeping alcohol to a minimum all reduce the load on a stomach that is already emptying slowly. Cold or room-temperature food can be easier to tolerate than hot dishes. Many people find the nausea is worst before 11am and improves by early afternoon, so shifting your injection timing (with your prescriber's guidance) is sometimes worth discussing. On the feeling full on Mounjaro page there is more on managing appetite changes alongside this.
If nausea is affecting your ability to eat or drink enough (particularly if you are vomiting repeatedly and struggling to keep fluids down) that is a clinical matter, not a lifestyle one. Dehydration on top of GI side effects can become serious quickly. Contact your prescriber or a healthcare professional the same day. Likewise, if nausea is accompanied by severe, persistent abdominal pain that spreads towards the back, seek urgent medical attention: this pattern can be a sign of pancreatitis, which the MHRA flagged in a drug safety update for GLP-1 medicines in January 2026 as an uncommon but serious risk requiring prompt assessment.
There is also a third scenario: nausea that is manageable but simply makes daily life unpleasant for weeks on end. This is worth raising with your prescriber too, because slowing the titration schedule (spending longer at a lower dose before stepping up) is sometimes the right clinical call. That decision belongs to them, not to a self-help article. You can see how private prescribing works, including the cost context, on our Mounjaro pricing page.
The adjustments that consistently make the biggest difference come down to pacing and portion. Eating until you are comfortably full rather than until the plate is clear matters more on tirzepatide than it ever did before, because gastric emptying is already slower than your body is used to. Overfilling a stomach that is working at half speed is the fastest route to feeling sick.
Protein and vegetables tend to be better tolerated than large amounts of refined carbohydrate or saturated fat. Ginger (in tea, biscuits, or capsule form) has reasonable evidence for mild nausea generally, though it has not been studied specifically in the context of GLP-1 medicines. Staying upright for at least thirty minutes after eating, rather than lying down, helps the stomach move food along. Plain water, sipped steadily through the day rather than drunk in large amounts at mealtimes, avoids the sensation of a full stomach before food even arrives.
One thing that catches people out is the morning routine. If you take your injection on a Monday, by Tuesday morning the medicine's peak plasma level is still rising. Some people find it easier to plan for Tuesday to be a lighter-eating day, nothing elaborate, just a piece of toast before the kettle has finished boiling and smaller portions at lunch. This is not a medical protocol, just a practical pattern that our prescribers say comes up in conversations with patients most weeks.
For broader wellbeing questions on treatment, the Mounjaro hub covers the full picture, and our FAQ page addresses common questions about the process. If you have concerns about other physical sensations alongside nausea (feeling cold, feeling weak, or sudden warmth) our pages on feeling cold on Mounjaro and feeling weak on Mounjaro offer relevant context.
If you are considering starting treatment and want a prescriber to review your situation, including whether tirzepatide is right for you, start your free consultation with our clinical team.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.